Literature DB >> 30685843

JNK Isoforms Are Involved in the Control of Adult Hippocampal Neurogenesis in Mice, Both in Physiological Conditions and in an Experimental Model of Temporal Lobe Epilepsy.

Rubén D Castro-Torres1,2,3, Jon Landa1, Marina Rabaza1, Oriol Busquets2,4,5,6, Jordi Olloquequi7, Miren Ettcheto2,4,5,6, Carlos Beas-Zarate3, Jaume Folch4,5, Antoni Camins2,5,6, Carme Auladell8,9,10, Ester Verdaguer1,5,6.   

Abstract

Neurogenesis in the adult dentate gyrus (DG) of the hippocampus allows the continuous generation of new neurons. This cellular process can be disturbed under specific environmental conditions, such as epileptic seizures; however, the underlying mechanisms responsible for their control remain largely unknown. Although different studies have linked the JNK (c-Jun-N-terminal-kinase) activity with the regulation of cell proliferation and differentiation, the specific function of JNK in controlling adult hippocampal neurogenesis is not well known. The purpose of this study was to analyze the role of JNK isoforms (JNK1/JNK2/JNK3) in adult-hippocampal neurogenesis. To achieve this goal, we used JNK-knockout mice (Jnk1-/-, Jnk2-/-, and Jnk3-/-), untreated and treated with intraperitoneal injections of kainic acid (KA), as an experimental model of epilepsy. In each condition, we identified cell subpopulations at different stages of neuronal maturation by immunohistochemical specific markers. In physiological conditions, we evidenced that JNK1 and JNK3 control the levels of one subtype of early progenitor cells (GFAP+/Sox2+) but not the GFAP+/Nestin+ cell subtype. Moreover, the absence of JNK1 induces an increase of immature neurons (Doublecortin+; PSA-NCAM+ cells) compared with wild-type (WT). On the other hand, Jnk1-/- and Jnk3-/- mice showed an increased capacity to maintain hippocampal homeostasis, since calbindin immunoreactivity is higher than in WT. An important fact is that, after KA injection, Jnk1-/- and Jnk3-/- mice show no increase in the different neurogenic cell subpopulation analyzed, in contrast to what occurs in WT and Jnk2-/- mice. All these data support that JNK isoforms are involved in the adult neurogenesis control.

Entities:  

Keywords:  Adult hippocampal neurogenesis; JNK isoforms; Kainic acid; Knockout mice

Mesh:

Substances:

Year:  2019        PMID: 30685843     DOI: 10.1007/s12035-019-1476-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  46 in total

Review 1.  Signal transduction by the JNK group of MAP kinases.

Authors:  R J Davis
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  Kainate, a double agent that generates seizures: two decades of progress.

Authors:  Y Ben-Ari; R Cossart
Journal:  Trends Neurosci       Date:  2000-11       Impact factor: 13.837

Review 3.  Injury-induced neurogenesis in the adult mammalian brain.

Authors:  Jack M Parent
Journal:  Neuroscientist       Date:  2003-08       Impact factor: 7.519

4.  The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development.

Authors:  C Y Kuan; D D Yang; D R Samanta Roy; R J Davis; P Rakic; R A Flavell
Journal:  Neuron       Date:  1999-04       Impact factor: 17.173

5.  Calretinin/PSA-NCAM immunoreactive granule cells after hippocampal damage produced by kainic acid and DEDTC treatment in mouse.

Authors:  María Isabel Domínguez; José Miguel Blasco-Ibáñez; Carlos Crespo; Ana Isabel Marqués-Marí; Francisco José Martínez-Guijarro
Journal:  Brain Res       Date:  2003-03-21       Impact factor: 3.252

6.  A critical role of neural-specific JNK3 for ischemic apoptosis.

Authors:  Chia-Yi Kuan; Alan J Whitmarsh; Derek D Yang; Guanghong Liao; Aryn J Schloemer; Chen Dong; Jue Bao; Kenneth J Banasiak; Gabriel G Haddad; Richard A Flavell; Roger J Davis; Pasko Rakic
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

7.  Transient calretinin expression defines early postmitotic step of neuronal differentiation in adult hippocampal neurogenesis of mice.

Authors:  Moritz D Brandt; Sebastian Jessberger; Barbara Steiner; Golo Kronenberg; Katja Reuter; Anika Bick-Sander; Wolfger von der Behrens; Gerd Kempermann
Journal:  Mol Cell Neurosci       Date:  2003-11       Impact factor: 4.314

8.  A central role for JNK in obesity and insulin resistance.

Authors:  Jiro Hirosumi; Gürol Tuncman; Lufen Chang; Cem Z Görgün; K Teoman Uysal; Kazuhisa Maeda; Michael Karin; Gökhan S Hotamisligil
Journal:  Nature       Date:  2002-11-21       Impact factor: 49.962

9.  Stable transfection of calbindin-D28k into the GH3 cell line alters calcium currents and intracellular calcium homeostasis.

Authors:  P M Lledo; B Somasundaram; A J Morton; P C Emson; W T Mason
Journal:  Neuron       Date:  1992-11       Impact factor: 17.173

10.  c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation.

Authors:  Dietrich Conze; Troy Krahl; Norman Kennedy; Linda Weiss; Joanne Lumsden; Patricia Hess; Richard A Flavell; Graham Le Gros; Roger J Davis; Mercedes Rincón
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Research progress on oxidative stress regulating different types of neuronal death caused by epileptic seizures.

Authors:  Haogang Sun; Xinxin Li; Qi Guo; Songyan Liu
Journal:  Neurol Sci       Date:  2022-08-04       Impact factor: 3.830

2.  Impact of JNK and Its Substrates on Dendritic Spine Morphology.

Authors:  Emilia Komulainen; Artemis Varidaki; Natalia Kulesskaya; Hasan Mohammad; Christel Sourander; Heikki Rauvala; Eleanor T Coffey
Journal:  Cells       Date:  2020-02-14       Impact factor: 6.600

Review 3.  Involvement of JNK1 in Neuronal Polarization During Brain Development.

Authors:  Rubén Darío Castro-Torres; Oriol Busquets; Antoni Parcerisas; Ester Verdaguer; Jordi Olloquequi; Miren Ettcheto; Carlos Beas-Zarate; Jaume Folch; Antoni Camins; Carme Auladell
Journal:  Cells       Date:  2020-08-13       Impact factor: 6.600

4.  Lipocalin-2 Deficiency Reduces Oxidative Stress and Neuroinflammation and Results in Attenuation of Kainic Acid-Induced Hippocampal Cell Death.

Authors:  Hyun Joo Shin; Eun Ae Jeong; Jong Youl Lee; Hyeong Seok An; Hye Min Jang; Yu Jeong Ahn; Jaewoong Lee; Kyung Eun Kim; Gu Seob Roh
Journal:  Antioxidants (Basel)       Date:  2021-01-12

5.  Teratogenic, Oxidative Stress and Behavioural Outcomes of Three Fungicides of Natural Origin (Equisetum arvense, Mimosa tenuiflora, Thymol) on Zebrafish (Danio rerio).

Authors:  Raquel Vieira; Carlos Venâncio; Luís Félix
Journal:  Toxics       Date:  2021-01-09

Review 6.  JNK Pathway in CNS Pathologies.

Authors:  Teresa de Los Reyes Corrales; María Losada-Pérez; Sergio Casas-Tintó
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

Review 7.  Brain JNK and metabolic disease.

Authors:  Rubén Nogueiras; Guadalupe Sabio
Journal:  Diabetologia       Date:  2020-11-16       Impact factor: 10.122

8.  Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer's disease in metabolically stressed APPswe/PS1dE9 mice.

Authors:  Miren Ettcheto; Elena Sánchez-Lopez; Amanda Cano; Marina Carrasco; Katherine Herrera; Patricia R Manzine; Triana Espinosa-Jimenez; Oriol Busquets; Ester Verdaguer; Jordi Olloquequi; Carme Auladell; Jaume Folch; Antoni Camins
Journal:  Cell Biosci       Date:  2021-07-22       Impact factor: 7.133

Review 9.  Biological Properties of JNK3 and Its Function in Neurons, Astrocytes, Pancreatic β-Cells and Cardiovascular Cells.

Authors:  Rei Nakano; Tomohiro Nakayama; Hiroshi Sugiya
Journal:  Cells       Date:  2020-07-29       Impact factor: 6.600

Review 10.  Role of c-Jun N-Terminal Kinases (JNKs) in Epilepsy and Metabolic Cognitive Impairment.

Authors:  Oriol Busquets; Miren Ettcheto; Amanda Cano; Patricia R Manzine; Elena Sánchez-Lopez; Triana Espinosa-Jiménez; Ester Verdaguer; Rubén Dario Castro-Torres; Carlos Beas-Zarate; Francesc X Sureda; Jordi Olloquequi; Carme Auladell; Jaume Folch; Antoni Camins
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.